Oxidative modification of lipoprotein(a) and the effect of beta-carotene.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Metabolism: Clinical and Experimental

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 1435294
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Malondialdehyde modification of lipoprotein(a) produces avid uptake by human monocyte-macrophages.

  1992cited by this paper
• Oxidation of lipoprotein Lp(a). A comparison with low-density lipoproteins.

  1991cited by this paper
• beta-Carotene inhibits the oxidative modification of low-density lipoprotein.

  1991cited by this paper
• Quantification of apo[a] and apoB in human atherosclerotic lesions.

  1991cited by this paper
• Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages.

  1991cited by this paper
• Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits.

  1990cited by this paper
• Lipoprotein (a). Heterogeneity and biological relevance.

  1990cited by this paper
• Detection of new epitopes formed upon oxidation of low-density lipoprotein, lipoprotein (a) and very-low-density lipoprotein. Use of an antiserum against 4-hydroxynonenal-modified low-density lipoprotein.

  1990cited by this paper
• Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophages.

  1989cited by this paper
• Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients.

  1989cited by this paper
• A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein.

  1989cited by this paper
• Quantitation and localization of apolipoproteins [a] and B in coronary artery bypass vein grafts resected at re-operation.

  1989cited by this paper
• Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

  1989cited by this paper
• Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.

  1989cited by this paper
• The mysteries of lipoprotein(a).

  1989cited by this paper
• A selective bi-site immunoenzymatic procedure for human Lp[a] lipoprotein quantification using monoclonal antibodies against apo[a] and apoB.

  1989cited by this paper
• Modification of the Recalde method for the isolation of human monocytes.

  1988cited by this paper
• Enhanced Macrophage Uptake of Low Density Lipoprotein after Self‐Aggregation

  1988cited by this paper
• Interaction of lipoprotein Lp(a) and low density lipoprotein with glycosaminoglycans from human aorta.

  1988cited by this paper
• The linkage with apolipoprotein (a) in lipoprotein (a) modifies the immunochemical and functional properties of apolipoprotein B.

  1988cited by this paper
• Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes.

  1987cited by this paper
• Superoxide initiates oxidation of low density lipoprotein by human monocytes.

  1987cited by this paper
• Decrease in Reactive Amino Groups during Oxidation or Endothelial Cell Modification of LDL: Correlation with Changes in Receptor‐Mediated Cataboiism

  1987cited by this paper
• Lipid transfer protein-catalyzed exchange of cholesteryl ester between high density lipoproteins and apoB-containing lipoproteins.

  1987cited by this paper
• Probucol inhibits oxidative modification of low density lipoprotein.

  1986cited by this paper
• Modification of human low-density lipoprotein by the lipid peroxidation product 4-hydroxynonenal.

  1986cited by this paper
• Fat feeding in humans induces lipoproteins of density less than 1.006 that are enriched in apolipoprotein [a] and that cause lipid accumulation in macrophages.

  1986cited by this paper
• Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a).

  1985cited by this paper
• Heterogeneity of human plasma lipoprotein (a). Isolation and characterization of the lipoprotein subspecies and their apoproteins.

  1984cited by this paper
• Simultaneous determination of plasma retinol, alpha-tocopherol, lycopene, alpha-carotene, and beta-carotene by high-performance liquid chromatography.

  1984cited by this paper
• Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.

  1984cited by this paper
• Enhanced Macrophage Degradation of Biologically Modified Low Density Lipoprotein

  1983cited by this paper
• In vitro studies on the aggregation of isolated lipoprotein(a) upon addition of lysolecithin.

  1983cited by this paper
• Protein composition of Lp(a) lipoprotein from human plasma

  1983cited by this paper
• Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen).

  1981cited by this paper
• Lipoprotein (a) is not a metabolic product of other lipoproteins containing apolipoprotein B.

  1979cited by this paper
• Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method.

  1978cited by this paper
• Procedure for determination of free and total cholesterol in micro- or nanogram amounts suitable for studies with cultured cells.

  1978cited by this paper
• Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts.

  1976cited by this paper
• Uptake and degradation of low density lipoprotein by swine arterial smoot muscle cells with inhibition of cholesterol biosynthesis.

  1976cited by this paper
• Cytochalasin B. Dissociation of pinocytosis and phagocytosis by peritoneal macrophages.

  1973cited by this paper
• Determination of free amino groups in proteins by trinitrobenzenesulfonic acid.

  1966cited by this paper
• The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

  1955cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Lipoprotein(a): An Independent Risk factor of Cardiovascular Disease

  2022cites this paper
• Lipoprotein(a), an Opsonin, Enhances the Phagocytosis of Nontypeable Haemophilus influenzae by Macrophages

  2021cites this paper
• Association of vitamins, minerals, and lead with Lipoprotein(a) in a cross-sectional cohort of US adults.

  2021cites this paper
• The effects of fermented wheat powder (Lisosan G) on the blood lipids and oxidative status of healthy rabbits.

  2015cites this paper
• Selected thrombosis and atherosclerosis risk factors in children with idiopathic nephrotic syndrome

  2012cites this paper
• Marcadores inflamatórios de instabilidade da placa aterosclerótica coronária : caraterização e potencial utilização clínica

  2012cites this paper
• Lipoprotein (a) and Cardiovascular Risk

  2012cites this paper
• Health Consequences of Vegetarian Diets

  2010cites this paper
• The Relationship between Uric Acid Concentration and Some of Plasma Lipids in Patients with C. V. Disease in General Hospital of Al-Nasseriya

  2009cites this paper
• Lipoprotein(a) levels in girls with premature adrenarche

  2008cites this paper
• EFFECT OF CHEMICAL MODIFICATION INDUCED BY COPPER OXIDATION ON LIPOPROTEIN (A) BINDING SITE FUNCTION

  2006cites this paper
• Lipoprotein(a): involved in events, but not burden of atherosclerotic disease?

  2006cites this paper
• Elevated lipoprotein(a)--a genetic risk factor for premature vascular disease in people with and without standard risk factors: a review.

  2006cites this paper
• Protective role of flavonoids in cardiovascular diseases

  2005cites this paper
• Novel serologic markers of cardiovascular risk

  2005cites this paper
• Stability and Synergistic Effect of Antioxidative Properties of Lycopene and Other Active Components

  2004cites this paper
• The effect of estrogens and phytoestrogenic lignans on macrophage uptake of atherogenic lipoproteins

  2004cites this paper
• The susceptibility of lipoprotein(a) to copper oxidation is correlated with the susceptibility of autologous low density lipoprotein to oxidation.

  2003cites this paper
• Detection of IgG-bound lipoprotein(a) immune complexes in patients with coronary heart disease.

  2003cites this paper
• Dietary carotenoids and risk of coronary artery disease in women.

  2003cites this paper
• Mitogenic Activity of Oxidized Lipoprotein (a) on Human Vascular Smooth Muscle Cells

  2002cites this paper
• Elevated serum lipoprotein(a) level is an independent marker of severity of thoracic aortic atherosclerosis.

  2002cites this paper
• Effect of Native Lp ( a ) or Oxidized Lp ( a ) on VSMC Growth

  2002cites this paper
• A Critical Evaluation of the Role of Lp(a) in Cardiovascular Disease: Can Lp(a) Be Useful in Risk Assessment?

  2002cites this paper
• Dietary flavonoids and risk of coronary heart disease.

  2001cites this paper
• Relationship of Early Carotid Artery Disease With Lipoprotein (a), Apolipoprotein B, and Fibrinogen in Asymptomatic Essential Hypertensive Patients and Normotensive Subjects

  2001cites this paper
• Atherosclerosis and autoimmunity

  2001cites this paper
• Oxidized lipoprotein(a) increases the expression of platelet-derived growth factor-B in human umbilical vein endothelial cells.

  2000cites this paper
• Protein kinase Cb mediates lipoprotein-induced generation of PAI-1 from vascular endothelial cells

  2000cites this paper
• Development of Antibody Against Epitope of Lipoprotein(a) Modified by Oxidation: Evaluation of New Enzyme-Linked Immunosorbent Assay for Oxidized Lipoprotein(a)

  2000cites this paper
• Lipoprotein(a) oxidation and autoantibodies: a new path in atherothrombosis

  2000cites this paper
• Endothelium-dependent vasorelaxation in the aorta of transgenic mice expressing human apolipoprotein(a) or lipoprotein(a).

  2000cites this paper
• Inhibition of inducible nitric oxide synthesis by oxidized lipoprotein(a) in a murine macrophage cell line

  2000cites this paper
• Oxidized lipoprotein(a) enhanced the expression of P-selectin in cultured human umbilical vein endothelial cells.

  2000cites this paper
• Protein kinase C-beta mediates lipoprotein-induced generation of PAI-1 from vascular endothelial cells.

  2000cites this paper
• Novel risk factors for atherosclerosis.

  2000cites this paper
• Diabetic nephropathy in non-insulin dependent diabetes mellitus. Cardiovascular risk factors and antihypertensive treatment.

  2000cites this paper
• AENDO April 41/4

  2000cites this paper
• Tocotrienol: a review of its therapeutic potential.

  1999cites this paper
• Potential New Cardiovascular Risk Factors: Left Ventricular Hypertrophy, Homocysteine, Lipoprotein(a), Triglycerides, Oxidative Stress, and Fibrinogen

  1999cites this paper
• Screening for cardiovascular disease. Concepts, conflicts, and consensus.

  1999cites this paper
• Autoantibodies against malondialdehyde-modified lipoprotein(a) in antiphospholipid syndrome.

  1999cites this paper
• Should one routinely screen for lipoprotein(a)?

  1999cites this paper
• Elevated plasma levels of soluble P-selectin in patients with acute myocardial infarction and unstable angina. An inverse link to lipoprotein(a).

  1998cites this paper
• The interaction of modified low density lipoproteins with glomerular mesangial cells and its potential influence on glomerulosclerosis

  1998cites this paper
• Topological defects and the optimum size of DNA condensates.

  1998cites this paper
• Measurement of oxidation in plasma Lp(a) in CAPD patients using a novel ELISA.

  1998cites this paper
• Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study.

  1998cites this paper
• Atherothrombogenicity of lipoprotein(a): the debate.

  1998cites this paper
• Lipid Profile and Peripheral Vascular Disease in Arseniasis-Hyperendemic Villages in Taiwan

  1997cites this paper
• Lipoprotein(a): structural implications for pathophysiology

  1997cites this paper
• Relationships between Fatty Acid Composition and Insulin–induced Oxidizability of Low–Density Lipoproteins in Healthy Men a

  1997cites this paper
• Structural basis for the pathophysiology of lipoprotein(a) in the athero-thrombotic process.

  1997cites this paper
• Native and gamma radiolysis-oxidized lipoprotein(a) increase the adhesiveness of rabbit aortic endothelium.

  1997cites this paper
• Lipoprotein Lp(a) excess and coronary heart disease.

  1997cites this paper
• Oxidative modification enhances lipoprotein(a)-induced overproduction of plasminogen activator inhibitor-1 in cultured vascular endothelial cells.

  1997cites this paper
• Oxidation of apolipoprotein(a) inhibits kringle‐associated lysine binding: The loss of intrinsic protein fluorescence suggests a role for tryptophan residues in the lysine binding site

  1997cites this paper
• A simple and rapid purification procedure minimizes spontaneous oxidative modifications of low density lipoprotein and lipoprotein (a).

  1997cites this paper
• Increased Lipoprotein Oxidability and Aortic Lipid Peroxidation in an Experimental Model of Insulin Resistance Syndrome a

  1997cites this paper
• Oxidatively modified LDL and atherosclerosis: an evolving plausible scenario.

  1996cites this paper
• Lipoprotein(a) induces cell growth in rat peritoneal macrophages through inhibition of transforming growth factor-beta activation.

  1996cites this paper
• How often has Lp(a) evolved?

  1996cites this paper
• Electrophoretic methods for quantitation of lipoprotein [a].

  1996cites this paper
• PAF-acetylhydrolase activity of Lp(a) before and during Cu(2+)-induced oxidative modification in vitro.

  1996cites this paper
• Modification of lipoprotein(a) by oxidation or desialylation influences its ability to compete with plasminogen for binding to the extracellular matrix.

  1996cites this paper
• Effect of dietary supplementation of beta-carotene on human monocyte-macrophage-mediated oxidation of low density lipoprotein.

  1996cites this paper
• Oxidation of lipoprotein(a) and low density lipoprotein containing density gradient ultracentrifugation fractions.

  1996cites this paper
• Interaction of native and oxidized lipoprotein(a) with human mesangial cells and matrix.

  1996cites this paper
• Oxidized lipoprotein (a) induces cell adhesion molecule Mac-1 (CD 11b) and enhances adhesion of the monocytic cell line U937 to cultured endothelial cells.

  1996cites this paper
• Plasma lipoprotein(a) distribution in the Framingham Offspring Study as determined with a commercially available immunoturbidimetric assay.

  1996cites this paper
• Resistance of lipoprotein(a) to lipid peroxidation induced by oxygenated free radicals produced by gamma radiolysis: a comparison with low-density lipoprotein.

  1996cites this paper
• Effect of antioxidants alone and in combination with monounsaturated fatty acid-enriched diets on lipoprotein oxidation.

  1996cites this paper
• The influence of molecular biology on our understanding of lipoprotein metabolism and the pathobiology of atherosclerosis.

  1995cites this paper
• Impairment of endothelium-dependent dilation in rabbit renal arteries by oxidized lipoprotein(a). Role of oxygen-derived radicals.

  1995cites this paper
• Lipoprotein (a).

  1995cites this paper
• Oxidized LDL and lipoprotein(a) stimulate renin release of juxtaglomerular cells.

  1995cites this paper
• Lipoprotein(a), Plasmin Modulation, and Atherogenesis

  1995cites this paper
• Lipoprotein(a) and asymptomatic carotid artery disease. Evidence of a prominent role in the evolution of advanced carotid plaques: the Bruneck Study.

  1995cites this paper
• Plant carotenoids and related molecules: important dietary antioxidants.

  1995cites this paper
• Lipoprotein (a) displays increased accumulation compared with low-density lipoprotein in the murine arterial wall.

  1994cites this paper
• Lipoprotein (a)

  1994cites this paper
• Lipoprotein (a): implication in atherothrombosis.

  1994cites this paper
• Lipoprotein(a) and atherogenesis.

  1994cites this paper
• A rapid and simple method for measuring the susceptibility of low-density-lipoprotein and very-low-density-lipoprotein to copper-catalyzed oxidation.

  1994cites this paper
• Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial.

  1994cites this paper
• Oxidative modification of Lp(a) causes changes in the structure and biological properties of apo(a).

  1994cites this paper
• Susceptibility of human LDL to oxidative modification. Effects of variations in beta-carotene concentration and oxygen tension.

  1994cites this paper
• Oxidized lipoprotein(a) inhibits endothelium-dependent dilation: prevention by high density lipoprotein.

  1994cites this paper
• LIPOPROTEIN(α) IN HEALTH AND DISEASE

  1994cites this paper
• Effect of Combined Supplementation With C‐Tocopherol, Ascorbate, and Beta Carotene on Low‐Densit Lipoprotein Oxidation

  1993cites this paper
• Biological Functions of Dietary Carotenoids

  1993cites this paper
• Oxidized LDL and antioxidants

  1993cites this paper
• The relation of lipoprotein[a] concentrations and apolipoprotein[a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study.

  1993cites this paper
• Influence of probucol on enhanced LDL oxidation after fish oil treatment of hypertriglyceridemic patients.

  1993cites this paper
• Studies on the Ability of Dietary Supplementation with β‐Carotene to Protect Low‐Density Lipoprotein from Oxidative Modification

  1993cites this paper
• Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation.

  1993cites this paper
• Probucol protects lipoprotein (a) against oxidative modification.

  1992cites this paper